COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021

Published:2021-08-06 Issue:31 Volume:70 Page:1053-1058
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Hause Anne M.,Gee Julianne,Baggs James,Abara Winston E.,Marquez Paige,Thompson Deborah,Su John R.,Licata Charles,Rosenblum Hannah G.,Myers Tanya R.,Shimabukuro Tom T.,Shay David K.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health(social science),Epidemiology

Reference10 articles.

1. Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine emergency use authorization review memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. https://www.fda.gov/media/144416/download

2. Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine EUA amendment review memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https://www.fda.gov/media/148542/download

3. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents.;Frenck;N Engl J Med,2021

4. Shay DK, Shimabukuro TT, DeStefano F. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA Cardiol 2021. Epub June 29, 2021. 10.1001/jamacardio.2021.2821

5. Israeli Ministry of Health. Surveillance of myocarditis (inflammation of the heart muscle) cases between December 2020 and May 2021 [Press release]. Jerusalem, Israel: Israeli Ministry of Health; 2021. https://www.gov.il/en/departments/news/01062021-03

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence of Myopericarditis Following COVID-19 Vaccination Among Adults in the Eastern Region, Saudi Arabia: A Multicenter Study;International Journal of General Medicine;2024-07

2. Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review;Cardiology in Review;2024-06-06

3. Vaccinating with Valor: A Risk Preventive Model to Explain Factors in Parents’ Choice to Vaccinate Their Children for COVID-19;Health Communication;2024-04-09

4. Overview of U.S. COVID-19 vaccine safety surveillance systems;Vaccine;2024-04

5. A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection;Heliyon;2024-03